Nucleai logo

Nucleai

The leading Spatial Biology Software Platform for Precision Medicine.

105 employees · est. 2018 · Chicago, United States

VS
Singular Genomics logo

Singular Genomics

Accelerating multiomics for the advancement of science and medicine.

163 employees · est. 2016 · San Diego, United States

Singular Genomics is the older company (2018 vs 2016).

Side-by-Side Comparison

Nucleai Singular Genomics
Founded
2018 2016 older
Headquarters
Chicago, United States San Diego, United States
Employees
105 163
Industry
AI, Health Care, Machine Learning Biotechnology, Health Care
Funding Stage
Series Unknown Acquired
Total Funding
$60.50M $303.60M
Funding Rounds
4 6
Services
Not tracked yet High Throughput Spatial Sequencing, Spatial and Multiomic Data Generation, Custom RNA and Protein Panels, 3D Biological Insights, Sequencing Support
Target Customers
Not tracked yet Pathology Departments, Cancer Research Institutes, Biotech and Pharma Companies, Academic Medical Centers, Clinical Researchers
Taxonomy
Spatial Biology, Precision Medicine, AI-powered Technology, Drug Development, Clinical Treatment Decisions, Patient Outcomes, Pharmaceutical Companies, Research Platform, Biomarkers Discovery, Medical Technology Multiomics, Spatial Pathology, Precision Diagnostics, Personalized Medicine, Life Science Technology, Next Generation Sequencing, Singular Sequencing Engine, NGS Market, G4 Integrated Solution, PX Integrated Solution, Single Cell Analysis, Spatial Analysis, Genomics, Proteomics
Website
nucleai.ai singulargenomics.com
Nucleai logo

About Nucleai

Nucleai is a healthcare startup founded in 2017 and headquartered in the United States. The company's slogan, "The leading Spatial Biology Software Platform for Precision Medicine," exemplifies their focus on leveraging AI-powered spatial biology technology to advance precision medicine. Nucleai's e...

Singular Genomics logo

About Singular Genomics

Singular Genomics, founded in 2016, is a pioneering force in the Biotechnology and Health Care sectors. Headquartered in the United States, this innovative company is at the forefront of delivering the future of spatial pathology, guided by its slogan, "Accelerating multiomics for the advancement of...

We will tell you when either one moves

BounceWatch watches Nucleai and Singular Genomics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Nucleai and Singular Genomics — by email.

Frequently Asked Questions

Nucleai — The leading Spatial Biology Software Platform for Precision Medicine. . Singular Genomics — Accelerating multiomics for the advancement of science and medicine. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Nucleai has raised $60.50M while Singular Genomics has raised $303.60M.
Nucleai and Singular Genomics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Nucleai with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Nucleai on 12 Sep 2024, and Singular Genomics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy